Riskpilot← Back to searchSign inGet full accessS.L Medconsult AB
ABActiveOrg 5593479073SundsvallTemporary employment agency activities and other human resource provisions · NACE 7820Est. 20211 employees
Revenue 2025
SEK 144K
+18% vs 2024
EBITDA margin
45.5%
+217% vs 2024
Equity ratio
90.1%
Financial strength
Net profit 2025
SEK 54K
+55806% vs 2024
| Revenue | SEK 144K | +18% |
| EBITDA | SEK 66K | +217% |
| Net profit | SEK 54K | +55806% |
| Total assets | SEK 149K | +62% |
| Equity | SEK 134K | +66% |
| Employees | 1 | — |
Legal name
S.L Medconsult AB
Org number
5593479073
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
23 november 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna Firman tecknas ensam av externa firmatecknaren
Company purpose
Konsult inom hälso- och sjukvård.
Address
Sundsvall
Email
info@formabolag.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 1 099 | 698 | 122 | 144 |
| Staff expenses | −584 | −359 | −69 | −14 |
| EBITDA | 405 | 233 | −56 | 66 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 405 | 233 | −56 | 66 |
| Net financials | 0 | 0 | 0 | 0 |
| Profit before tax | 405 | 175 | 0 | 68 |
| Tax | −83 | −36 | −0 | −14 |
| Net profit | 321 | 139 | 0 | 54 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 490 | 323 | 92 | 149 |
| Equity | 346 | 166 | 81 | 134 |
| Long-term debt | — | — | — | — |
| Short-term debt | 144 | 99 | 9 | 15 |
| Total debt | 144 | 99 | 9 | 15 |
EBITDA margin
45.5%
This company
15.8%
Market median
+188% vs market
20222025
Equity ratio
90.1%
This company
38.2%
Market median
+136% vs market
20222025
Return on equity
39.9%
This company
18.4%
Market median
+117% vs market
20222025
Net profit margin
37.3%
This company
8.1%
Market median
+360% vs market
20222025
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20222025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-23 – 2022-11-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EB External Signatory | External Signatory | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2026 | |
| Deputy Board Member | 2026 | |
| Deputy Board Member | 2026 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of S.L Medconsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva-Lena Birgitta Johansson Olsson | External Signatory | 0 companies |
| Anna Louise Jönsson | Deputy Board Member | 0 companies |
| Therese Anna Maria Bratteberg | Board of Directors | 0 companies |
| Eva Maria Birberg | Deputy Board Member | 0 companies |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 0 companies |
| Jan Stefan Lövenfeldt | Board of Directors | 0 companies |